|
Total no. of gastric lesions
|
299
| |
|
Age (years, mean ± SD)
|
71.6 ± 9.1
| |
|
Sex
|
|
Male
|
225
|
(75.3)
|
|
Female
|
74
|
(24.7)
|
|
Under antithrombotic therapy
|
81
|
(27.1)
|
|
Single antiplatelet agent
|
52
| |
|
≥ 2 antiplatelet agents
|
11
| |
|
Single anticoagulant agent
|
12
| |
|
Antiplatelet(s) plus anticoagulant
|
6
| |
|
On hemodialysis
|
1
|
(0.3)
|
|
Tumor location
|
|
Upper third
|
47
|
(15.7)
|
|
Middle third
|
142
|
(47.5)
|
|
Lower third
|
110
|
(36.8)
|
|
Length of the resected specimen (mm, mean ± SD)
|
36.4 ± 15.3
|
|
Morphology
|
|
Elevated
|
174
|
(58.2)
|
|
Flat or depressed
|
125
|
(41.8)
|
|
Pathology
|
|
Adenoma
|
51
|
(17.1)
|
|
Adenocarcinoma, differentiated type
|
231
|
(77.3)
|
|
Adenocarcinoma, undifferentiated type
|
17
|
(5.7)
|
|
Depth of invasion
|
|
M
|
263
|
(88.0)
|
|
SM, ≤ 500 mm (micrometer)
|
16
|
(5.4)
|
|
SM, > 500 mm (micrometer)
|
20
|
(6.7)
|
|
Ulcer scar within the lesion
|
16
|
(5.4)
|
|
Curative resection by ESD
|
266
|
(89.0)
|
